Smith Graham & Co. Investment Advisors LP decreased its holdings in Select Medical Holdings Co. (NYSE:SEM) by 13.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 578,827 shares of the health services provider’s stock after selling 92,790 shares during the quarter. Select Medical accounts for about 1.0% of Smith Graham & Co. Investment Advisors LP’s investment portfolio, making the stock its 27th largest position. Smith Graham & Co. Investment Advisors LP owned approximately 0.43% of Select Medical worth $10,216,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Parametric Portfolio Associates LLC boosted its holdings in shares of Select Medical by 3.0% in the second quarter. Parametric Portfolio Associates LLC now owns 390,052 shares of the health services provider’s stock worth $5,987,000 after buying an additional 11,245 shares during the last quarter. Parametrica Management Ltd purchased a new position in shares of Select Medical in the third quarter worth approximately $653,000. Chicago Equity Partners LLC purchased a new position in shares of Select Medical in the third quarter worth approximately $1,105,000. Affinity Wealth Management purchased a new position in shares of Select Medical in the third quarter worth approximately $429,000. Finally, Cubist Systematic Strategies LLC purchased a new position in shares of Select Medical in the third quarter worth approximately $1,748,000. 77.90% of the stock is currently owned by institutional investors.
In other news, insider Martin F. Jackson sold 156,603 shares of the business’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $17.06, for a total value of $2,671,647.18. Following the transaction, the insider now owns 1,790,601 shares of the company’s stock, valued at $30,547,653.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michael E. Tarvin sold 18,500 shares of the business’s stock in a transaction on Monday, October 30th. The stock was sold at an average price of $18.97, for a total transaction of $350,945.00. Following the completion of the transaction, the insider now directly owns 340,044 shares in the company, valued at approximately $6,450,634.68. The disclosure for this sale can be found here. Insiders have sold 314,455 shares of company stock worth $5,403,144 in the last ninety days. Insiders own 19.93% of the company’s stock.
Shares of Select Medical Holdings Co. (SEM) traded up $0.15 during trading hours on Monday, reaching $17.50. 807,000 shares of the company’s stock traded hands, compared to its average volume of 736,169. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.51 and a quick ratio of 1.51. Select Medical Holdings Co. has a twelve month low of $12.00 and a twelve month high of $19.77. The stock has a market capitalization of $2,341.93, a P/E ratio of 23.97, a P/E/G ratio of 1.11 and a beta of 1.34.
Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, November 2nd. The health services provider reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.02). Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The firm had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the prior year, the firm earned $0.06 EPS. Select Medical’s revenue for the quarter was up 4.1% compared to the same quarter last year. research analysts expect that Select Medical Holdings Co. will post 0.86 EPS for the current year.
A number of research firms recently issued reports on SEM. Zacks Investment Research downgraded shares of Select Medical from a “hold” rating to a “sell” rating in a report on Friday, October 27th. Robert W. Baird set a $25.00 price target on shares of Select Medical and gave the company a “buy” rating in a report on Monday, October 23rd. Bank of America raised shares of Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 price target on the stock in a report on Thursday, January 4th. Royal Bank of Canada reaffirmed a “buy” rating and set a $19.00 price target on shares of Select Medical in a report on Friday, October 13th. Finally, ValuEngine raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $19.43.
TRADEMARK VIOLATION NOTICE: “Smith Graham & Co. Investment Advisors LP Reduces Position in Select Medical Holdings Co. (SEM)” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/22/smith-graham-co-investment-advisors-lp-reduces-position-in-select-medical-holdings-co-sem.html.
Select Medical Company Profile
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.